Discontinued — last reported Q2 '23
Johnson & Johnson Consumer — Amortization remained flat by 0.0% to $100.00M in Q2 2023 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $100.00M to $100.00M. This is a positive signal — lower values indicate better performance for this metric.
High amortization levels often reflect significant past acquisition activity, impacting reported net income without affecting cash flow.
This represents the non-cash expense related to the systematic write-down of intangible assets, such as patents or trade...
Standard accounting disclosure for companies with significant intangible assets from M&A.
jnj_segment_consumer_health_amortization| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|
| Value | $100.00M | $100.00M | $100.00M | $100.00M | $100.00M | $100.00M | $100.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% |